Analytik Jena Reports Sales and Earnings Growth in First Quarter of 2010/2011
Incoming orders reach record level in first quarter
The manufacturer of analytical, bioanalytical and optical systems and molecular diagnostic reagents reported particularly strong sales and order development in its largest division, Analytical Instrumentation, which generated sales of EUR 14.5 m in the first three months of the current financial year - up 17.2 % on the same period of the previous year. The Optics division, whose business had suffered from the global economic crisis in the past two financial years, also returned to sales growth with a figure of EUR 1.2 m, a year-on-year improvement of 15.1 %. Sales in the growth segment of Life Science remained constant in the first quarter at EUR 8.0 m (previous year: EUR 8.1 m).
"Analytik Jena has enjoyed an extremely positive first quarter, returning to the stable business development it has seen over the past six years following the non-recurring effects that impacted results in the second half of the 2009/2010 financial year," commented Klaus Berka, CEO of Analytik Jena AG. "This excellent start to the financial year is important and will provide a solid basis for significant sales and earnings growth across all three divisions in the 2010/2011 financial year as a whole."
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.